Abstract
Objective
To investigate the impact of serum small and dense low-density lipoprotein (sd-LDL) on contrast-induced acute kidney injury (CI-AKI) after emergency percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).
Method
From November 2019 to August 2020, 352 patients with STEMI who underwent primary PCI were recruited consecutively. Patients were divided into CI-AKI group (n = 71) and non-CI-AKI group (n = 281). CI-AKI was defined as an increase in serum creatinine (≥ 25% or ≥ 0.5 mg/dL) from baseline occurring 72 h after PCI. All subjects were tested for sd-LDL.
Results
In the 352 eligible patients with STEMI receiving emergency PCI, 71 patients (20.2%) developed CI-AKI. The levels of sd-LDL in CI-AKI group was higher than those in the non-CI-AKI group, and the difference was statistically significant (P < 0.05). The area under the curve (AUC) of the sd-LDL was 0.741 [95% confidence interval (CI) 0.538–0.636] in the STEMI patients receiving emergency PCI. CI-AKI model included the following five predictors: sd-LDL, NLR, Diabetes, Pre-PCI eGFR, and Log NT-proBNP. The AUC of forecast probability was 0.835 [95% confidence interval (CI) 0.786–0.883].The Hosmer–Lemeshow test has a P value of 0.519, which confirms the model’s goodness of fit.
Conclusion
Increased sd-LDL is independently associated with risk of CI-AKI in STEMI patients treated by primary PCI.
Similar content being viewed by others
References
Inokuchi R, Hara Y, Yasuda H, Itami N, Terada Y, Doi K (2017) Differences in characteristics and outcomes between community- and hospital-acquired acute kidney injury: a systematic review and meta-analysis. Clin Nephrol 88(10):167–182
Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. The New England J Med 380(22):2146–2155
Afanasieva OI, Utkina EA, Artemieva NV, Ezhov MV, Adamova IY, Pokrovsky SN (2016) Kardiologiia 56(6):5–11
Tsujita K, Yamanaga K, Komura N, Sakamoto K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Investigators PRECISE-IVUS (2016) Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: subanalysis of PRECISE-IVUS trial. Atherosclerosis 251:367–372
Bansal SK, Yadav R (2016) A study of the extended lipid profile including oxidized LDL, small dense LDL, lipoprotein (a) and apolipoproteins in the assessment of cardiovascular risk in hypothyroid patients. J Clin Diagn Res: JCDR 10(6):BC04–BC08
Shen H, Xu Y, Lu J, Ma C, Zhou Y, Li Q, Chen X, Zhu A, Shen G (2016) Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients. BMC Nephrology 17(1):143
Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Peco-Antic A, Kostic M, Vasic D, Spasic S (2011) Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients. Transplant Int: Off J Euro Soc Organ Transplant 24(11):1094–1102
Weisbord, S. D., Gallagher, M., Jneid, H., Garcia, S., Cass, A., Thwin, S. S., Conner, T. A., Chertow, G. M., Bhatt, D. L., Shunk, K., Parikh, C. R., McFalls, E. O., Brophy, M., Ferguson, R., Wu, H., Androsenko, M., Myles, J., Kaufman, J., Palevsky, P. M., & PRESERVE Trial Group (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. The New England J Med 378(7):603–614
Hossain MA, Costanzo E, Cosentino J, Patel C, Qaisar H, Singh V, Khan T, Cheng JS, Asif A, Vachharajani TJ (2018) Contrast-induced nephropathy: pathophysiology, risk factors, and prevention. Saudi J Kidney Dis Transplant: Off Publ Saudi Center Organ Transplant, Saudi Arabia 29(1):1–9
Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M, Dua A, Short L, Kane K (2014) Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet (London, England) 383(9931):1814–1823
Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE (2017) Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet (London, England) 389(10076):1312–1322
Li G, Wu HK, Wu XW, Cao Z, Tu YC, Ma Y, Wang WQ, Cheng J, Zhou ZH (2018) Small dense low density lipoprotein-cholesterol and cholesterol ratios to predict arterial stiffness progression in normotensive subjects over a 5 year period. Lipid Health Dis 17(1):27
Moreno-Gordaliza E, Esteban-Fernández D, Lázaro A, Aboulmagd S, Humanes B, Tejedor A, Linscheid MW, Gómez-Gómez MM (2018) Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity. J Lipid Res 59(9):1561–1574
Gyebi L, Soltani Z, Reisin E (2012) Lipid nephrotoxicity: new concept for an old disease. Curr Hypertens Rep 14(2):177–181
Heyman SN, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am SocNephrol: CJASN 3(1):288–296
McDonald JS, Leake CB, McDonald RJ, Gulati R, Katzberg RW, Williamson EE, Kallmes DF (2016) Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort. Invest Radiol 51(12):804–809
McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271(1):65–73
Gao F, Zhou YJ, Zhu X, Wang ZJ, Yang SW, Shen H (2011) C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol 34(3):203–210
Wilhelm-Leen E, Montez-Rath ME, Chertow G (2017) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol: JASN 28(2):653–659
Afari ME, Bhat T (2016) Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther 14(5):573–577
Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A (2018) Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Biomed Res Int 2018:2703518
Yu S, Arima H, Bertmar C, Clarke S, Herkes G, Krause M (2018) Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke. J Neurol Sci 387:115–118
Kurtul A, Yarlioglues M, Duran M, Murat SN (2016) Association of neutrophil-to-lymphocyte ratio with contrast-induced nephropathy in patients with Non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention. Heart Lung Circ 25(7):683–690
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Contributions
YL, KM and WL contributed in the conception of the work, conducting the study, revising the draft, approval of the final version of the manuscript, and agreed for all aspects of the work. YL, KM, GS, DZ, YX and WL contributed in the conception of the work, drafting and revising the draft. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Y., Ma, K., Shen, G. et al. Impact of small and dense low-density lipoprotein (sd-LDL)on contrast-induced acute kidney injury in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Urol Nephrol 53, 2611–2617 (2021). https://doi.org/10.1007/s11255-021-02821-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02821-x